Search

Search Constraints

You searched for: Author/Creator Inzucchi, Silvio E.

Search Results

1. A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy. (3rd October 2017)

2. A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF). (21st March 2019)

3. Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?. Issue 4 (3rd January 2020)

4. Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME. Issue 7 (28th March 2020)

5. Association of inpatient and outpatient glucose management with inpatient mortality among patients with and without diabetes at a major academic medical center. Issue 4 (28th January 2015)

6. Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus. Issue 20 (16th May 2017)

7. Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME. Issue 4 (23rd January 2018)

10. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association. Issue 19 (12th May 2020)